ES2094335T3 - Derivados de alopurinol aminoacilados y oligopeptidos de actividad inmunoestimuladora y composiciones farmaceuticas que los contienen. - Google Patents

Derivados de alopurinol aminoacilados y oligopeptidos de actividad inmunoestimuladora y composiciones farmaceuticas que los contienen.

Info

Publication number
ES2094335T3
ES2094335T3 ES92830136T ES92830136T ES2094335T3 ES 2094335 T3 ES2094335 T3 ES 2094335T3 ES 92830136 T ES92830136 T ES 92830136T ES 92830136 T ES92830136 T ES 92830136T ES 2094335 T3 ES2094335 T3 ES 2094335T3
Authority
ES
Spain
Prior art keywords
alopurinol
derivatives
aciled
oligopeptides
immuno
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92830136T
Other languages
English (en)
Inventor
Mauro Marzi
Patrizia Minetti
Piero Foresta
Maria Ornella Tinti
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sigma Tau Industrie Farmaceutiche Riunite SpA
Original Assignee
Sigma Tau Industrie Farmaceutiche Riunite SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Industrie Farmaceutiche Riunite SpA filed Critical Sigma Tau Industrie Farmaceutiche Riunite SpA
Application granted granted Critical
Publication of ES2094335T3 publication Critical patent/ES2094335T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

DERIVADOS AMINOACIL Y OLIGOPEPTIDIL DE ALOPURINOL QUE EXHIBEN ACTIVIDAD INMUNOESTIMULATORIA, Y FORMULACIONES FARMACEUTICAS QUE CONTIENEN ESTAS SUBSTANCIAS. LA PRESENTE INVENCION SE REFIERE A DERIVADOS AMINOACIL Y OLIOGOPEPTIDIL DE ALOPURINOL (1, 5-DIHIDRO-4H-PIRAZOLO D] ELACIONADAS CON CATIONES FARMACOLOGICAMENTE ACEPTABLES, EN LA MENCIONADA FORMULA N ES UN ENTERO ENTRE 2 Y 6, PREFERIBLEMENTE 5, Y ES H O CO-A, EN DONDE A ES UN ACIDO AMINO RACEMICO O QUIRAL, BIPEPTIDO, TRIPEPTIDO, TETRAPEPTIDO, O PENTAPEPTIDO ESCOGIDO, RESPECTIVAMENTE, ENTRE LOS GRUPOS QUE CONSTAN DE: A) ARGININA, ACIDO ASPARTICO, LISINA, LEUCINA; B) GLICILASPARTATO, GLICILGLICINA, ASPARTILARGININA, LEUCILARGININA, ALANIGLICINA; C) ARGINILLISILASPARTATO, ASPARTILLISILARGININA, LISILPROLILARGININA, PROLILPROLILARGININA, LISILISTIDIGLICINAMIDA, PROLILFENILALANILARGININA, FENILALANILPROLILARGININA; D) ARGINILLISILASPARTILVALINA, VALILASPARTILLISILARGININA, TREONILVALILLEUCILHISTIDINA; E) ARGINILLISILASPARTILVALILTRIOSINA.
ES92830136T 1991-03-22 1992-03-20 Derivados de alopurinol aminoacilados y oligopeptidos de actividad inmunoestimuladora y composiciones farmaceuticas que los contienen. Expired - Lifetime ES2094335T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITRM910189A IT1244501B (it) 1991-03-22 1991-03-22 Derivati amminoacilici e oligopeptidici dell'allopurinolo dotati di attivita' immunostimolante e composizioni farmaceutiche che li contengono

Publications (1)

Publication Number Publication Date
ES2094335T3 true ES2094335T3 (es) 1997-01-16

Family

ID=11399991

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92830136T Expired - Lifetime ES2094335T3 (es) 1991-03-22 1992-03-20 Derivados de alopurinol aminoacilados y oligopeptidos de actividad inmunoestimuladora y composiciones farmaceuticas que los contienen.

Country Status (10)

Country Link
US (1) US5272151A (es)
EP (1) EP0506628B1 (es)
JP (1) JP3067886B2 (es)
AT (1) ATE143024T1 (es)
DE (1) DE69213794T2 (es)
DK (1) DK0506628T3 (es)
ES (1) ES2094335T3 (es)
GR (1) GR3021556T3 (es)
HK (1) HK1006462A1 (es)
IT (1) IT1244501B (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5928191A (en) * 1993-07-30 1999-07-27 E.P. Technologies, Inc. Variable curve electrophysiology catheter
US5994361A (en) * 1994-06-22 1999-11-30 Biochem Pharma Substituted purinyl derivatives with immunomodulating activity
WO1999024038A1 (en) 1997-11-07 1999-05-20 Johns Hopkins University Methods for treatment of disorders of cardiac contractility
ES2232169T3 (es) 1998-08-12 2005-05-16 Gilead Sciences, Inc. Procedimiento de fabricacion de nucleosidos de 1,3-oxatiolano.
CA2788498C (en) * 2001-03-01 2016-02-16 Gilead Sciences, Inc. Polymorphic and other crystalline forms of cis-ftc
AU2002364160A1 (en) * 2001-12-14 2003-06-30 Pharmasset Ltd. Preparation of intermediates useful in the synthesis of antiviral nucleosides
CA2494183C (en) 2002-08-06 2012-01-03 Kyoichi A. Watanabe Processes for preparing 1,3-dioxolane nucleosides
US6953041B2 (en) * 2002-10-09 2005-10-11 Micell Technologies, Inc. Compositions of transition metal species in dense phase carbon dioxide and methods of use thereof
CA2552122A1 (en) * 2003-12-29 2005-07-21 Advanced Medical Optics, Inc. Intraocular lenses having a visible light-selective-transmissive-region
US7067659B2 (en) * 2004-04-23 2006-06-27 Duke University Reactive oxygen generating enzyme inhibitor with nitric oxide bioactivity and uses thereof
BRPI0509338B1 (pt) 2004-04-30 2017-10-17 Abbott Medical Optics Inc. Detached devices having a highly selective violet light transmitter and related methods
EP1815275B1 (en) * 2004-11-22 2011-02-23 Abbott Medical Optics Inc. Copolymerizable azo compounds and articles containing them
ATE525664T1 (de) * 2004-11-22 2011-10-15 Abbott Medical Optics Inc Copolymerisierbare methin- und anthrachinon- verbindungen und artikel damit
US8188098B2 (en) * 2008-05-19 2012-05-29 Hoffmann-La Roche Inc. GPR119 receptor agonists
EP3915565A3 (en) * 2013-03-15 2022-03-16 XORTX Therapeutics Inc. Xanthine oxidase inhibitor formulations

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3165520A (en) * 1965-01-12 Certificate of correction
AU564576B2 (en) * 1981-09-24 1987-08-20 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Purine derivatives
US4602089A (en) * 1982-03-12 1986-07-22 Newport Pharmaceuticals, Inc. Process for preparing purine compounds
DK302883D0 (da) * 1983-06-30 1983-06-30 Hans Bundgaard Allopurinol prodrugs
US4663326A (en) * 1985-04-04 1987-05-05 Warner-Lambert Company Pyrazolo[4,3-d]pyrimidine-5,7-(4H,6H)dione or -5-thione-7-one analogs
AU611648B2 (en) * 1986-08-11 1991-06-20 Baxter International Inc. Pivot pin bearing/seal with loose eyelet especially suited for disposable continuous flow blood filtration system cartridges
IT1213495B (it) * 1986-09-17 1989-12-20 Sigma Tau Ind Farmaceuti Processo per la preparazione dell'alfa-n-[(ipoxatin-9-il)pentilossicarbonil-]arginina

Also Published As

Publication number Publication date
EP0506628B1 (en) 1996-09-18
DE69213794T2 (de) 1997-02-06
ITRM910189A1 (it) 1992-09-22
ATE143024T1 (de) 1996-10-15
DE69213794D1 (de) 1996-10-24
GR3021556T3 (en) 1997-02-28
EP0506628A3 (en) 1992-10-21
US5272151A (en) 1993-12-21
HK1006462A1 (en) 1999-02-26
JPH05117275A (ja) 1993-05-14
DK0506628T3 (da) 1996-11-11
JP3067886B2 (ja) 2000-07-24
ITRM910189A0 (it) 1991-03-22
IT1244501B (it) 1994-07-15
EP0506628A2 (en) 1992-09-30

Similar Documents

Publication Publication Date Title
ES2094335T3 (es) Derivados de alopurinol aminoacilados y oligopeptidos de actividad inmunoestimuladora y composiciones farmaceuticas que los contienen.
ATE513847T1 (de) Bioaktive peptide
ES2136662T3 (es) Formas de presentacion farmaceuticas y de otro tipo.
EP0254080A3 (en) Malonic acid derivatives and methods for their synthesis
DK0781781T3 (da) Camptothecinderivater
ES2161886T3 (es) Composiciones en barra de gel que comprenden gelificantes opticamente enriquecidos.
ID21956A (id) Asam n-(aril dan atau heteroarilasetil) amino ester, komposisi farmasi yang mengandungnya, dan metoda untuk menghambat pelepasan betha-amiloid peptida dan atau sintesanya dengan menggunakan senyawa tersebut
ES2117390T3 (es) Sales de un acido graso poliinsaturado y formulaciones farmaceuticas que las contienen.
FR2744134B1 (fr) Proteines de reserve de plantes enrichies en acides amines, notamment alpha-zeine de mais enrichie en lysine plantes exprimant ces proteines
CO4790174A1 (es) Analogos del peptido lh-rh, sus usos y composiciones farmaceuticas que los contienen
IT1244548B (it) Derivati della 5-oxo-l-prolina e loro applicazioni farmaceutiche
IL154995A0 (en) Polypeptide bombesin antagonists, their preparation and pharmaceutical preparations containing them
ES2196187T3 (es) Conjugados peptidicos derivados de las hormonas timicas, su utilizacion a titulo de medicamento y composiciones que los contienen.
MX9302327A (es) Aminoacidos ciclicos novedosos y derivados de los mismos.
ITRM910070A1 (it) Derivati degli acidi dicarbossilici aventi da sei a dodici atomi di carbonio ed impiego di tali derivati e degli acidi stessi per la preparazione di composizioni farmaceutiche atte all'alimentazione enterale parenterale.
ATE65086T1 (de) Peptidderivate von cck8, deren herstellung und sie enthaltende pharmazeutische zusammensetzungen.
AP1734A (en) Crystalline forms of 1S-[1alpha(2S*,3*), 9 alpha]-6, 10-dioxo-N-(2-ethoxy-5- oxo-tetrahydro-3-furanyl)-9-[[(isoquinolyl) carbonyl]-amino] octahydro-6H-piridazino[1,2-A][1,2] diazepin- 1-carboxamide.
AU639751B2 (en) Temporary minimal protection synthesis of lh-rh analogs
ES2091571T3 (es) Nuevos derivados peptidicos activos en los procesos de adhesion celular, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
ES2070229T3 (es) Nuevos hexapeptidos activos sobre el sistema nervioso central (snc) con efecto antiamnesico.
HUP9902307A2 (hu) Új, áthidalt gyűrűs aminosavak, előállításuk és intermedierjeik
IT1247493B (it) Sali ad attivita' antiinfiammatoria, analgesica e antipiretica e composizioni farmaceutiche che li contengono

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 506628

Country of ref document: ES